Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy-volunteers” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 263
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 263 pipeline programs matching "healthy-volunteers" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

263 results for “healthy-volunteers” Back to intelligence hub

Search results

Page 2 of 11
  1. AG221

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  2. AG881

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  3. AG881 Formulation 1

    Agios Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  4. AGMB-129

    Agomab Therapeutics NV

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  5. AKB-6548

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  6. AKB-6548 (therapeutic dose)

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  7. AKB-9090

    Akebia Europe Limited

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  8. ALN-4285

    Alnylam Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  9. ALN-4915

    Alnylam Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule active

    1 trial
  10. ALN-AGT01 RVR

    Alnylam Netherlands B.V.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  11. ALN-ANG3

    Regeneron UK Limited

    Healthy Volunteers With Hyperlipidemia

    phase 1 small molecule active

    1 trial
  12. ALPN-101

    CNS Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  13. AN2-502998

    AN2 Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. AT-527 + digoxin

    Atea Pharmaceuticals

    Healthy Volunteers Study

    phase 1 small molecule completed

    1 trial
  15. Alogliptin

    Takeda

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  16. Amphetamine

    NEUROCRINE BIOSCIENCES INC

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  17. Aramchol

    Galmed Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  18. Arbaclofen Placarbil SR

    Indivior Pty Ltd

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  19. Aspirin

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  20. Atorvastatin

    Aligos Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  21. Atumelnant

    Crinetics Pharmaceuticals Europe GmbH

    Healthy Volunteers

    phase 1 small molecule active

    2 trials
  22. BBP-671

    BridgeBio Oncology Therapeutics

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial
  23. BG-71332

    BEONE MEDICINES AUS PTY LTD

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  24. BGB-16673

    BEONE MEDICINES AUS PTY LTD

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.